Hims & Hers Health (HIMS) Revenue & Revenue Breakdown
Hims & Hers Health Revenue Highlights
Latest Revenue (Y)
$1.48B
Latest Revenue (Q)
$598.98M
Hims & Hers Health Revenue by Period
Hims & Hers Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.48B | 69.33% |
| 2023-12-31 | $872.00M | 65.49% |
| 2022-12-31 | $526.92M | 93.81% |
| 2021-12-31 | $271.88M | 82.77% |
| 2020-12-31 | $148.76M | 80.18% |
| 2019-12-31 | $82.56M | 209.45% |
| 2018-12-31 | $26.68M | - |
Hims & Hers Health generated $1.48B in revenue during NA 2024, up 69.33% compared to the previous quarter, and up 1788.46% compared to the same period a year ago.
Hims & Hers Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $598.98M | 9.94% |
| 2025-06-30 | $544.83M | -7.03% |
| 2025-03-31 | $586.01M | 21.80% |
| 2024-12-31 | $481.14M | 19.82% |
| 2024-09-30 | $401.56M | 27.22% |
| 2024-06-30 | $315.65M | 13.47% |
| 2024-03-31 | $278.17M | 12.79% |
| 2023-12-31 | $246.62M | 8.79% |
| 2023-09-30 | $226.70M | 9.04% |
| 2023-06-30 | $207.91M | 8.99% |
| 2023-03-31 | $190.77M | 14.09% |
| 2022-12-31 | $167.20M | 15.44% |
| 2022-09-30 | $144.84M | 27.54% |
| 2022-06-30 | $113.56M | 12.09% |
| 2022-03-31 | $101.31M | 19.62% |
| 2021-12-31 | $84.70M | 14.19% |
| 2021-09-30 | $74.17M | 22.21% |
| 2021-06-30 | $60.69M | 16.01% |
| 2021-03-31 | $52.31M | 26.16% |
| 2020-12-31 | $41.47M | 0.34% |
| 2020-09-30 | $41.32M | 15.10% |
| 2020-06-30 | $35.90M | 19.43% |
| 2020-03-31 | $30.06M | 21.37% |
| 2019-12-31 | $24.77M | 14.23% |
| 2019-09-30 | $21.68M | 20.12% |
| 2019-06-30 | $18.05M | - |
| 2019-03-31 | $18.05M | - |
Hims & Hers Health generated $598.98M in revenue during Q3 2025, up 9.94% compared to the previous quarter, and up 189.76% compared to the same period a year ago.
Hims & Hers Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BAX | Baxter | $4.51B | $2.83B |
| ENSG | Ensign Group | $4.26B | $1.30B |
| ALGN | Align | $4.00B | $995.69M |
| MRNA | Moderna | $3.24B | $143.00M |
| BMRN | BioMarin Pharmaceutical | $2.85B | $776.13M |
| RVTY | Revvity | $2.76B | $698.95M |
| QGEN | Qiagen | $1.97B | $458.80M |
| HIMS | Hims & Hers Health | $1.48B | $598.98M |
| HQY | HealthEquity | $1.20B | $325.83M |
| PEN | Penumbra | $1.19B | $339.45M |
| TECH | Bio-Techne | $1.16B | $286.56M |